Expression of SIRT1 in gastric cardiac cancer and its clinicopathologic significance

International Journal of Surgical Pathology

Volumn 19, Issue 6, 2011, Pages 743-750

  Feng, An Ning ^a   Zhang, Li Hua ^b   Fan, Xiang Shan ^a   Huang, Qin ^c   Ye, Qing ^a   Wu, Hong Yan ^a   Yang, Jun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

gastric cardiac carcinoma; Ki 67; p53; prognosis; SIRT1

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; SIRTUIN 1;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GASTRIC CARDIAC CARCINOMA; HEART CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; TISSUE MICROARRAY;

ADENOCARCINOMA; CARDIA; CELL NUCLEUS; CHINA; FEMALE; GASTRECTOMY; HUMANS; KI-67 ANTIGEN; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; SIRTUIN 1; STOMACH NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860253067     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896911412181     Document Type: Article

References (46)

1. Blander G, Guarente L.. The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004 ; 73: 417-435 (Pubitemid 39050375)
2. Imai S, Armstrong CM, Kaeberlein M, Guarente L.. Transcriptional silcencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000 ; 403: 795-800 (Pubitemid 30111843)
3. Voelter-Mahlnecht S, Mahlknecht U. Cloning. chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med. 2006 ; 17: 59-67
4. Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P, Reinberg D.. Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell. 2004 ; 16: 93-105 (Pubitemid 39330155)
5. Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001 ; 107: 137-148 (Pubitemid 33035941)
6. Vaziri H, Dessain SK, Ng Eaton E, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001 ; 107: 149-159 (Pubitemid 33035942)
7. Jung-Hynes B, Nihal M, Zhong W, Ahmad N.. Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?. J Biol Chem. 2009 ; 284: 3823-3832
8. Araki T, Sasaki Y, Milbrandt J.. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004 ; 305: 1010-1013 (Pubitemid 39071777)
9. Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 2006 ; 4: e31
10. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell. 2005 ; 123: 437-448 (Pubitemid 41546674)
11. Hida Y, Kubo Y, Murao K, Arase S.. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res. 2007 ; 299: 103-106 (Pubitemid 46669407)
12. Huffman DM, Grizzle WE, Bamman MM, et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007 ; 67: 6612-6618 (Pubitemid 47105506)
13. Potet F, Flejou JF, Gervaz H, Paraf F.. Adenocarcinoma of the lower esophagus and the esophagogastric junction. Semin Diagn Pathol. 1991 ; 8: 126-136
14. Misumi A, Murakami A, Harada K, Baba K, Akagi M.. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir. 1989 ; 374: 221-226 (Pubitemid 19175311)
15. Stemmermann GN, Fenoglio-Preiser C.. Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precursors to a preventable cancer. Pathology. 2002 ; 34: 494-503 (Pubitemid 36026724)
16. Keeney S, Bauer TL. Epidemiology of adenocarcinoma of the esophagogastric junction. Surg Oncol Clin N Am. 2006 ; 15: 687-696 (Pubitemid 44499031)
17. Sakata H, Fujimoto K.. Barrett's esophagus and Helicobacter pylori [in Japanese]. Nippon Rinsho. 2005 ; 63: 1383-1386
18. Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol. 2006 ; 101: 926-933 (Pubitemid 43725303)
19. Schumpelick V, Dreuw B, Ophoff K, Fass J.. Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux-surgical results in 122 patients [in German]. Leber Magen Darm. 1996 ; 26: 75-86 (Pubitemid 26121017)
20. Saito H, Fukumoto Y, Osaki T, et al. Distinct recurrence pattern and outcome the adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg. 2006 ; 30: 1864-1869 (Pubitemid 44455000)
21. Jang KY, Hwang SH, Kwon KS, et al. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol. 2008 ; 32: 1523-1531
22. Cha EJ, Noh SJ, Kwon KS, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res. 2009 ; 15: 4453-4459
23. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997 ; 88: 323-331 (Pubitemid 27131374)
24. Lozano G, Elledge SJ. p53 sends nucleotides to repair DNA. Nature. 2000 ; 404: 24-25 (Pubitemid 30143112)
25. Ford J, Jiang M, Milnier J.. Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res. 2005 ; 65: 10457-10463 (Pubitemid 41743740)
26. Ota H, Tokunaga E, Chang K, et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 2006 ; 25: 176-185 (Pubitemid 43083679)
27. Heltweg B, Gatbonton T, Schuler AD, et al. Antitumor activity of a small-molecule inhibitor of thuman silent information regulator 2 enzymes. Cancer Res. 2006 ; 66: 4368-4377
28. Sun Y, Sun D, Li F, et al. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. Lung Cancer. 2007 ; 58: 21-29 (Pubitemid 47385929)
29. Nemoto S, Fergusson MM, Finkel T.. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science. 2004 ; 306: 2105-2108 (Pubitemid 40007664)
30. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008 ; 105: 13421-13426
31. Ramires M.. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse type carcinomas. J Pathol. 1997 ; 182: 62-67 (Pubitemid 27240450)
32. Kojima K, Ohhashi R, Fujita Y, et al. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun. 2008 ; 373: 423-428
33. Huang J, Gan Q, Han L, et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE. 2008 ; 3 (3). e1710
34. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y.. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol. 2007 ; 43: 571-579 (Pubitemid 47615048)
35. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem. 2002 ; 277: 16547-16552 (Pubitemid 34967670)
36. Somasundaram K.. Tumor suppressor p53: regulation and function. Front Biosci. 2001 ; 5: D424 - D437
37. Blander G, Bhimavarapu A, Mammone T, et al. SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol. 2009 ; 129: 41-49
38. Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE. 2008 ; 3 (4). e2020
39. Narala SR, Allsopp RC, Wells TB, et al. SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity. Mol Biol Cell. 2008 ; 19: 1210-1219 (Pubitemid 351481832)
40. Fu M, Liu M, Sauve AA, et al. Hormonal control of androgen receptor function through SIRT1. Mol Cell Biol. 2006 ; 26: 8122-8135 (Pubitemid 44631010)
41. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002 ; 95: 2096-2102 (Pubitemid 35253370)
42. Cai L, Zheng ZL, Zhang ZF. Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World J Gastroenterol. 2003 ; 9: 214-218 (Pubitemid 36215791)
43. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000 ; 89: 1874-1882
44. Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Intl J Surg Pathol. 2007 ; 15: 1-15
45. Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, Faller DV. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor. Mol Endocrinol. 2007 ; 21: 1807-1821 (Pubitemid 47173793)
46. Pruitt K, Zinn RL, Ohm JE, et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hepermethylation. PLoS Genet. 2006 ; 2 (3). e40